Investor Center

Infinity Medical was established to harness innovative startups and bring digital health solutions to the world. Our focus is on advanced digital health technologies, with portfolio companies on the cutting edge of health innovation, in transition from development to global sales. Infinity medical team consists of experts in the fields of medicine, technology, business and finance. Our experience and confidence are reflected in our public company status (TASE:IMED.L).

IMED.L

Ticker

402

Last price

-12.4%

Change

Last update: 20:32 05/08/21 (GMT +3)

From The Press

Sinopharm, the developer of the Chinese vaccine, is starting operations in Israel

Infinity Medical (IMED) has signed a partnership with GuoJian Capital who manages 130…

Prof. Rivka Carmi has been appointed a director of the Infinity Medical R&D partnership

Prof. Rivka Carmi, former President of Ben-Gurion University, has been appointed director of…

The Chinese capital market is expected to become the equivalent of Wall Street in about a decade

With a meteoric rise in business activity and the IPO market alongside government…

Three doctors tell why they preferred to change direction towards the business world

In an interview with Walla, Dr. Yuval Bloch, CEO of Infinity Medical, explains…

China opens its bond market to foreign investors for the first time

A series of additional steps that China is taking for the first time…

Infinity Medical has signed a cooperation agreement with a Chinese investment company from the Sinopharm Group

Chinese Synopharm belongs to the group of companies from which the Chinese vaccine…

What is expected in 2021 in the field of digital health?

“The Corona virus uncovered the failures of the healthcare system, one of them…

China’s Capital Markets Webinar

China’s Capital Market: The Main Growth Engine of 2020s Foreign Capital Opportunities in…

Sinopharm, the developer of the Chinese vaccine, is starting operations in Israel

Infinity Medical (IMED) has signed a partnership with GuoJian Capital who manages 130…

Prof. Rivka Carmi has been appointed a director of the Infinity Medical R&D partnership

Prof. Rivka Carmi, former President of Ben-Gurion University, has been appointed director of…

The Chinese capital market is expected to become the equivalent of Wall Street in about a decade

With a meteoric rise in business activity and the IPO market alongside government…

Three doctors tell why they preferred to change direction towards the business world

In an interview with Walla, Dr. Yuval Bloch, CEO of Infinity Medical, explains…

China opens its bond market to foreign investors for the first time

A series of additional steps that China is taking for the first time…

Infinity Medical has signed a cooperation agreement with a Chinese investment company from the Sinopharm Group

Chinese Synopharm belongs to the group of companies from which the Chinese vaccine…

What is expected in 2021 in the field of digital health?

“The Corona virus uncovered the failures of the healthcare system, one of them…

China’s Capital Markets Webinar

China’s Capital Market: The Main Growth Engine of 2020s Foreign Capital Opportunities in…